Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody

Journal of Microbiology, Immunology and Infection

Volumn 38, Issue 5, 2005, Pages 365-369

  Yang, Chung Han ^a   Chen, Ji Yih ^a   Lee, Shih Ching ^a   Luo, Shue Fen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Congenital heart defects; Heart block; Plasmapheresis; SS A antibodies; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; RO ANTIBODY;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; CONGENITAL HEART BLOCK; FEMALE; FETUS DEATH; HUMAN; IMMUNOASSAY; NEPHROTIC SYNDROME; NEWBORN; NEWBORN DEATH; OLIGOHYDRAMNIOS; PANCYTOPENIA; PLASMAPHERESIS; POLYARTHRITIS; PREGNANCY; PROGNOSIS; RISK FACTOR; SJOEGREN SYNDROME; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN;

ADULT; ANTIBODIES, ANTINUCLEAR; AZATHIOPRINE; DEXAMETHASONE; FEMALE; HEART BLOCK; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMAPHERESIS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 27644561906     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 2002;11:145-51.
2. Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002;11:716-21.
3. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
4. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
5. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120:544-51.
6. Brucato A, Jonzon A, Friedman D, Allan LD, Vignati G, Gasparini M, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus 2003;12:427-35.
7. Kaaja R, Julkunen H. Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum 2003;48:280-1.
8. Barclay CS, French MA, Ross LD, Sokol RJ. Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynaecol 1987;94:369-71.
9. Buyon J, Roubey R, Swersky S, Pompeo L, Parke A, Baxi L, et al. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol 1988;15: 1104-8.
10. van der Leij JN, Visser GH, Bink-Boelkens MT, Meilof JF, Kallenberg CG. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. Prenat Diagn 1994;14:1003-7.
11. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K. Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 1999;93:952-7.
12. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies. Arthritis Rheum 1987;30:44-9.
13. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol 1993;20:1204-7.
14. Matsushita H, Higashino M, Sekizuka N, Kurabayashi T, Takakuwa K, Tanaka K. Successful prenatal treatment of congenital heart block with ritodrine administered transplacentally. Arch Gynecol Obstet 2002;267:51-3.
15. Eronen M, Heikkila P, Teramo K. Congenital complete heart block in the fetus: hemodynamic features, antenatal treatment, and outcome in six cases. Pediatr Cardiol 2001;22:385-92.
16. Olah KS, Gee H. Fetal heart block associated with maternal anti-Ro (SS-A) antibody-current management. A review. Br J Obstet Gynaecol 1991;98:751-5.
17. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block. Lupus 1995;4:116-21.
18. Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000;86:236-9.
19. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999;42:2335-45.
20. Fesslova V, Mannarino S, Salice P, Boschetto C, Trespidi L, Acaia B, et al. Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus 2003;12:775-8.
21. Buyon JP, Clancy RM. Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus. Autoimmunity 2003; 36:41-50.
22. Boutjdir M, Chen L, Zhang ZH, Tseng CE, El-Sherif N, Buyon JP. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr Res 1998;44:11-9.
23. Copel JA, Buyon JP, Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995;173:1384-90.
24. Rosenthal D, Druzin M, Chin C, Dubin A. A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone. Obstet Gynecol 1998;92:689-91.
25. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003;62:1010-2.
26. Herreman G, Galezowski N, Saint-Joseph H. Letter to the editor. N Engl J of Med 1985;312:1329.